Six versus 2 weeks treatment with doxycycline in European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blinded, randomised and placebo-controlled trial

BACKGROUND: There is limited evidence regarding optimal duration of antibiotic treatment in neuroborreliosis. We aimed to compare efficacy and safety of oral doxycycline for 2 and 6 weeks in European Lyme neuroborreliosis (LNB). METHODS: The trial had a randomised, double-blinded, placebo-controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Solheim, Anne Marit, Lorentzen, Åslaug Rudjord, Dahlberg, Audun Olav, Flemmen, Heidi Øyen, Brune, Synne, Forselv, Kristine Johanne Nordstrøm, Pripp, Are Hugo, Bø, Margrete Halvorsen, Eikeland, Randi, Reiso, Harald, Mygland, Åse, Ljøstad, Unn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Neuroinfection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606522/
https://www.ncbi.nlm.nih.gov/pubmed/35896378
http://dx.doi.org/10.1136/jnnp-2022-329724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606522/
https://www.ncbi.nlm.nih.gov/pubmed/35896378
http://dx.doi.org/10.1136/jnnp-2022-329724

Ejemplares similares